These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Bobholz JA; Rao SM Curr Opin Neurol; 2003 Jun; 16(3):283-8. PubMed ID: 12858063 [TBL] [Abstract][Full Text] [Related]
3. The association between cognitive impairment and quality of life in patients with early multiple sclerosis. Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429 [TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment in multiple sclerosis. Jongen PJ; Ter Horst AT; Brands AM Minerva Med; 2012 Apr; 103(2):73-96. PubMed ID: 22513513 [TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment in multiple sclerosis. Hoffmann S; Tittgemeyer M; von Cramon DY Curr Opin Neurol; 2007 Jun; 20(3):275-80. PubMed ID: 17495620 [TBL] [Abstract][Full Text] [Related]
6. [A critical analysis of neuroimaging studies in relation to cognitive performance in multiple sclerosis patients]. Cruz-Gomez J; Belenguer-Benavides A; Gonzalez-Rosa JJ; Simon-Gozalbo A; Forn C Rev Neurol; 2011 Sep; 53(6):337-50. PubMed ID: 21894605 [TBL] [Abstract][Full Text] [Related]
7. Disease progression in pediatric multiple sclerosis: disparities between physical and neurocognitive outcomes. Yeh EA; Parrish JB; Weinstock-Guttman B Expert Rev Neurother; 2011 Mar; 11(3):433-40. PubMed ID: 21375448 [TBL] [Abstract][Full Text] [Related]
8. [Neuropsychological evaluation in multiple sclerosis]. Arnett P; Forn C Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522 [TBL] [Abstract][Full Text] [Related]
9. Neuropsychological aspects of childhood multiple sclerosis: an overview. Blaschek A; Storm van's Gravesande K; Heinen F; Pritsch M; Mall V; Calabrese P Neuropediatrics; 2012 Aug; 43(4):176-83. PubMed ID: 22605613 [TBL] [Abstract][Full Text] [Related]
10. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589 [TBL] [Abstract][Full Text] [Related]
11. Therapy-induced plasticity of cognitive functions in MS patients: insights from fMRI. Penner IK; Kappos L; Rausch M; Opwis K; Radü EW J Physiol Paris; 2006 Jun; 99(4-6):455-62. PubMed ID: 16713204 [TBL] [Abstract][Full Text] [Related]
12. Assessment and rehabilitation of cognitive impairment in multiple sclerosis. Messinis L; Kosmidis MH; Lyros E; Papathanasopoulos P Int Rev Psychiatry; 2010; 22(1):22-34. PubMed ID: 20233112 [TBL] [Abstract][Full Text] [Related]
13. The neuropsychiatry of multiple sclerosis: a review of recent developments. Ghaffar O; Feinstein A Curr Opin Psychiatry; 2007 May; 20(3):278-85. PubMed ID: 17415083 [TBL] [Abstract][Full Text] [Related]
14. The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue. Huolman S; Hämäläinen P; Vorobyev V; Ruutiainen J; Parkkola R; Laine T; Hämäläinen H Mult Scler; 2011 Nov; 17(11):1351-61. PubMed ID: 21846692 [TBL] [Abstract][Full Text] [Related]
15. MRI and cognition in multiple sclerosis. Filippi M; Rocca MA Neurol Sci; 2010 Nov; 31(Suppl 2):S231-4. PubMed ID: 20635114 [TBL] [Abstract][Full Text] [Related]